Armando Godoy Palomino
Armando Godoy Palomino publishes mostly in Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research and Biosimilars and Bioanalytical Methods.
- World rank
- #3,956,159 of 7,710,434 ranked researchers
- Rank in United States
- #1,081,660 of 1,627,098
- Works
- 24
- Citations
- 51
- Citations per work
- 2.1
What does Armando Godoy Palomino research?
Armando Godoy Palomino's work is mostly in Medicine (67%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1666.6%
- Medicine1666.6%
- Everything else623.4%
- Life Sciences210.0%
- 1Rheumatology33% of their works
- 2Radiology, Nuclear Medicine and Imaging10% of their works
- 3Immunology10% of their works
- 4Cardiology and Cardiovascular Medicine8% of their works
- 5Genetics8% of their works
- 6Pathology and Forensic Medicine7% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Monoclonal and Polyclonal Antibodies Research
- Biosimilars and Bioanalytical Methods
- Chronic Lymphocytic Leukemia Research
- Autoimmune Bullous Skin Diseases
- Urticaria and Related Conditions
- Patient Safety and Medication Errors
- Medical Malpractice and Liability Issues
Which keywords describe Armando Godoy Palomino's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Monoclonal Antibodies, Rituximab, Autoimmune, Diagnosis and Fc Receptors.
- Patient Safety Culture
- Malpractice Risk
- Urticaria
- Chronic Spontaneous Urticaria
- Healthcare Quality
- Genomic Aberrations
- Biosimilars
- Fc Receptors
- Autoimmune
- Monoclonal Antibodies
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Rituximab
- Diagnosis
- Therapeutic Antibodies
- Chronic Lymphocytic Leukemia
- Immunogenicity
- Bullous Pemphigoid
- Pemphigoid
- Defensive Medicine
- Medical Errors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Autoantibodies223 topics
- Inflammation161 topic
- Rheumatoid Arthritis161 topic
- Monoclonal Antibodies112 topics
- Rituximab82 topics
- Autoimmune62 topics
- Diagnosis62 topics
- Fc Receptors61 topic
- Therapeutic Antibodies61 topic
- Biosimilars51 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- Immunogenicity51 topic
- Healthcare Quality42 topics
- Bullous Pemphigoid31 topic
- Chronic Spontaneous Urticaria31 topic
- Pemphigoid31 topic
- Urticaria31 topic
- Defensive Medicine21 topic
- Malpractice Risk21 topic
- Medical Errors21 topic
- Patient Safety Culture21 topic
Where does Armando Godoy Palomino work?
Armando Godoy Palomino's main affiliation in the publication record is Center for Rheumatology, United States.
How many publications and citations does Armando Godoy Palomino have?
OpenAlex counts 24 works and 51 citations for Armando Godoy Palomino, an h-index of 2, ranking #3,956,159 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Armando Godoy Palomino. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.